AMClarity
AN ANEMOCYTE DIVISION
More than 25+ Years of Aseptic Processing and Product Expertise
Achieve True Visual Inspection Clarity.
Defect Standards & GMP Consulting Tailored for Pharmaceutical and Biotech.
Precision-engineered Defective Reference Sets and Robust Inspection Qualification to ensure compliance and product quality for your most innovative therapies.
AMClarity: Visual Inspection Confidence, Unlocked.
AMClarity, a specialized division of Anemocyte, is your strategic partner in establishing robust, compliant, and defensible visual inspection processes.
We eliminate uncertainty by providing two core services essential for high-stakes life science production: Precision-Mimicking Defective Reference Standards and Expert GMP Qualification & Training Services.
Key services:
Custom Defective Reference Sets:
Production line and its potential contamination sources designed to challenge and qualify both manual and automated inspection systems.
GMP Inspection Consulting:
Hands-on support, qualification protocols, and comprehensive training to elevate your team’s expertise and ensure strict regulatory adherence.
Highlight
We don’t just manufacture defects; we replicate your specific risks.
Every Reference Set begins with a deep-dive Risk Analysis of your production line, drug product, matrix formulation (appearance, viscosity, general characteristics), raw materials and potential contamination sources.
Engineered from the Root Cause up
By analyzing your process flow and material constraints, we create "Mimics" that represent the actual challenges your inspection system will face.
Data-Driven Defect Creation
Transforming your Risk Assessment data into physical, representative standards for robust validation.
Defect Kits Delivered in Record Time
Time is critical when managing defects. Receive your defect kits with a competitive delivery time. Speed, reliability, and the certainty of not losing a crucial minute. Order now and experience the difference.
The product expertise you need.
With over 25 years of accumulated expertise within Anemocyte’s legacy, AMClarity boasts unparalleled specialization in the visual inspection of high-value products.
We understand the nuances of:
Advanced Therapy Medicinal Products (ATMPs)
Biologics (Proteins, Peptides)
Nucleic Acid Therapies (DNA, RNA/mRNA)
Traditional Small Molecule Drugs
Defect classification
Defects are classified based on their impact on patient safety, product integrity, and regulatory compliance.
Critical defects
Are those which jeopardize human health, safety and the environment or which contravene legal requirements. They indicate inadequate sterility of the product.
Major defects
Are those which severely impair integrity and use of the packaging and lead to a loss of performance of the product.
Minor defects
Are those which represent a general lowering of quality but do not limit the function of the packaging.
Defect standard set
A Defect Standard Set (also known as Defect Library Set) is a pre-defined and verified collection of product units specifically designed to include both defective units and defect-free units.
A Defect Standard Set is used to establish Defect Kits as references to train, qualify, and challenge the effectiveness of manual / automated visual inspection.
We can manage the following primary packaging and format:
Syringes
Ampoules
Vials
Cartridges
Bags
The science behind visual inspection Clarity.
Manual Visual Inspection remains the gold standard to guarantee product compliance.
Despite the rise of automated systems, the human eye — supported by rigorous training and standardized protocols — provides an unparalleled level of adaptability for detecting extrinsic, intrinsic, and inherent particles. It is a fundamental commitment to patient safety and zero-defect quality culture.
Manual Visual Inspection remains the gold standard to guarantee product compliance.
Visual inspection outcomes are based on a Probability of Detection (PoD). MVI does not guarantee 100% detection of every single particles.
Large particles (>500 µm) fall in the Reject Zone — reliably detected. Very small particles fall in the Accept Zone — below the resolution limit of the human eye. In between lies the Grey Zone: a probabilistic region where detection varies drastically based on lighting, contrast, and operator fatigue.
A well-engineered Defect Standard Set must cover all three zones to qualify an inspection system with confidence.
Engineered from the root cause up.
Every Reference Set begins with a deep-dive Risk Analysis of your production line, drug product, matrix formulation, raw materials and potential contamination sources.
By analyzing your process flow and material constraints, we create “Mimics” — physical defect standards that represent the actual challenges your inspection system will face.
Defect classification is obtained by a Risk Assessment based on an FMEA approach, ensuring every defect type and size range is relevant to your specific product and packaging.
See our Manual Visual Inspection in action
Fill out the form below to get instant access to an exclusive, real-world visual inspection case study.
Ready to guarantee your product quality?
Connect with AMClarity today to build a visual inspection strategy that is compliant, efficient, and scientifically sound.
Fill the form or send a request to AMClarity@anemocyte.com
BONUS: Upon submitting this form, you will gain immediate, exclusive access to the complete data and technical results of our real-world validation study.
